Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
MJ Ramaiah, AD Tangutur, RR Manyam - Life sciences, 2021 - Elsevier
The role of genetic and epigenetic factors in tumor initiation and progression is well
documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA …
documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA …
Histone deacetylase 6 in cancer
T Li, C Zhang, S Hassan, X Liu, F Song, K Chen… - Journal of hematology & …, 2018 - Springer
Histone acetylation and deacetylation are important epigenetic mechanisms that regulate
gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of …
gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of …
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic …
DA Yardley, RR Ismail-Khan, B Melichar… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Entinostat is an oral isoform selective histone deacetylase inhibitor that targets
resistance to hormonal therapies in estrogen receptor–positive (ER+) breast cancer. This …
resistance to hormonal therapies in estrogen receptor–positive (ER+) breast cancer. This …
Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance
The liver executes versatile functions and is the chief organ for metabolism of
toxicants/xenobiotics. Hepatocellular carcinoma (HCC) is the most common primary liver …
toxicants/xenobiotics. Hepatocellular carcinoma (HCC) is the most common primary liver …
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of
small-molecule therapeutics acting through the regulation of the acetylation states of histone …
small-molecule therapeutics acting through the regulation of the acetylation states of histone …
Adverse drug reactions induced by valproic acid
RM Nanau, MG Neuman - Clinical biochemistry, 2013 - Elsevier
Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly
in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic …
in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic …
Histone deacetylases and mechanisms of regulation of gene expression
HP Chen, YT Zhao, TC Zhao - Critical Reviews™ in …, 2015 - dl.begellhouse.com
In recent years it has become widely recognized that histone modification plays a pivotal
role in controlling gene expression and is involved in a wide spectrum of disease regulation …
role in controlling gene expression and is involved in a wide spectrum of disease regulation …
Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma
MW Yang, LY Tao, YS Jiang, JY Yang, YM Huo, DJ Liu… - Cancer research, 2020 - AACR
Perineural invasion is a common feature of pancreatic ductal adenocarcinoma (PDAC).
Here, we investigated the effect of perineural invasion on the microenvironment and how …
Here, we investigated the effect of perineural invasion on the microenvironment and how …
Acetylation site specificities of lysine deacetylase inhibitors in human cells
C Schölz, BT Weinert, SA Wagner, P Beli… - Nature …, 2015 - nature.com
Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are being
investigated in clinical trials for treatment of cancer and other diseases. However, their …
investigated in clinical trials for treatment of cancer and other diseases. However, their …
Tumours associated with BAP1 mutations
Summary BAP1 (BRCA1-Associated Protein 1) was initially identified as a protein that binds
to BRCA1. BAP1 is a tumour suppressor that is believed to mediate its effects through …
to BRCA1. BAP1 is a tumour suppressor that is believed to mediate its effects through …